Large Scale Safety and Immunogenicity Study of a DTaP-Hep B-PRP-T Combined Vaccine Compared to Tritanrix HepB/Hib™, Both Given Concomitantly With OPV at 6, 10, and 14 Weeks of Age in Healthy Filipino Infants
Phase of Trial: Phase III
Latest Information Update: 21 Oct 2013
At a glance
- Drugs Hib-DTaP-hepatitis B vaccine (Primary) ; Hib-DTP hepatitis B vaccine (Tritanrix-HepB/Hiberix); Poliovirus vaccine live oral
- Indications Diphtheria; Hepatitis B; Influenza virus infections; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Sanofi
- 26 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Dec 2009 Planned end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 19 Sep 2006 New trial record.